www.medicinapropraxi.cz / Med. Praxi. 2025;22(4):243-251 / MEDICÍNA PRO PRAXI 251 PŘEHLEDOVÉ ČLÁNKY Kolorektální karcinom v ordinaci praktického lékaře – jak identifikovat osoby ve zvýšeném riziku a kdy vyšetřovat přímé příbuzné LITERATURA 1. Ferlay J, Ervik M, Lam F et al. Global Cancer Observatory: Cancer Today (2024). (cit. 2024-10-08). Lyon, France: International Agency for Research on Cancer. (online). Available from: https://gco.iarc.who.int/today. 2. Krejčí D, Mužík J, Šnábl I, Gregor J, Komenda M, Dušek L. Portál epidemiologie novotvarů v ČR (online). Masarykova univerzita, Brno, 2024. (cit. 2025-07-07). Available from: https://www.svod.cz. Verze 8.0.1 3. Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159(1):335-49.e15. 4. Rubin G, Walter F, Emery J, et al. Reimagining the diagnostic pathway for gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15(3):181-8. 5. GBD 2017 Colorectal Cancer Collaborators. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913-33. 6. Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22(36):8103-11. 7. McNabb S, Harrison TA, Albanes D, et al. Meta-analysis of 16 studies of the association of alcohol with colorectal cancer. Int J Cancer. 2020;146(3):861-873. 8. NICE. Behaviour change: individual approaches. Public health guideline (PH49). 2014. Available from: https://www. nice.org.uk/guidance/ph49. 9. Loomans-Kropp HA, Umar A. Increasing incidence of colorectal cancer in young adults. J Cancer Epidemiol. 2019;2019:9841295. 10. Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst. 2017;109(8):djw322. 11. van Leerdam ME, Roos VH, van Hooft JE, et al. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019;51(11):1082-1093. 12. Wilkinson AN, Lieberman D, Leontiadis GI, et al. Colorectal cancer screening for patients with a family history of colorectal cancer or adenomas. Can Fam Physician. 2019;65(11):784-789. 13. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639-51.e28. 14. Olén O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet. 2020 Jan 11;395(10218):123-131. 15. Wijnands AM, de Jong ME, Lutgens MWMD, et al. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology. 2021 Apr;160(5):1584-1598. 16. Sato Y, Tsujinaka S, Miura T, et al. Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management. Cancers (Basel). 2023;15(16):4154. 17. Suchánek Š. Screening kolorektálního karcinomu v České republice v roce 2022. Gastroent Hepatol 2022;76(5):371. 18. Bretthauer M, Løberg M, Wieszczy P, et al. Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. N Engl J Med. 2022;387(17):1547-1556. 19. Dominitz JA, Robertson DJ, Ahnen DJ, et al. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design. Am J Gastroenterol. 2017;112(11):1736-1746. 20. Sekiguchi M, Westerberg M, Ekbom A, et al. Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study. J Gastroenterol Hepatol. 2022;37(11):2120-2130. 21. Castells A, Quintero E, Bujanda L, et al. Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial. Lancet. 2025;405(10486):1231-1239. 22. Medina-Lara A, Grigore B, Lewis R, et al. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis. Health Technol Assess. 2020;24(66):1-332. 23. Ngo O, Hejcmanová K, Suchánek Š, et al. Coverage by examinations associated with early detection of colorectal neoplasia in the Czech Republic. Eur J Public Health. 2023;33(3):515-521. 24. Quinn L, Bird P, Remsing S, Reeves K, Lilford R. Unintended consequences of the 18-week referral to treatment standard in NHS England: a threshold analysis. BMJ Qual Saf. 2023;32(12):712-720. 25. Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC perspective on colorectal cancer screening. New England Journal of Medicine. 2018 May 3;378(18):1734-40. 26. Zavoral M, Suchanek S, Majek O, et al. Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol. 2014;20(14):3825-34. 27. Ponti A, Anttila A, Ronco G et al. Cancer Screening in the European Union (2017). Report of the Implementation of the Council Recommendation on Cancer Screening; 2017. Available from: https: //health.ec.europa.eu/system/files/2017-05/2017_ cancerscreening_2ndreportimplementation_en_0.pdf. Další literatura u autora a na www.medicinapropraxi.cz.
RkJQdWJsaXNoZXIy NDA4Mjc=